Figure 1.
Study design and patient disposition. *, After 43 AGHD patients and 10 controls had been tested, Geref Diagnostic (Serono) became unavailable. The study was completed by testing 10 more AGHD patients and 38 controls with macimorelin alone; **, two AGHD subjects could not be matched due to the combination of young age, high BMI, and estrogen use.